Jeffrey S. Hackman - 27 Sep 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Reporting relationship: Chairman, President, and Chief Executive Officer., Director
Issuer ticker: N/A
Reported as of: 27 Sep 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Sep 2023, 16:06:05 UTC
Prior SEC filing: 16 Feb 2023
Next SEC filing: 19 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Ryan M. Rourke Reed, Attorney-in-Fact

Key filing fact

Jeffrey S. Hackman filed Form 4 for Comera Life Sciences Holdings, Inc. on 28 Sep 2023.

Key facts

This page summarizes Jeffrey S. Hackman's Form 4 filing for Comera Life Sciences Holdings, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Sep 2023, 16:06.

Change

Previous filing in this sequence was filed on 16 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CMRA transaction Derivative

Stock Option (Right to Purchase)

Award

Transaction value: $0
Shares: +600,000
Change %
Price: $0.000000
Shares after: 600,000
Date: 27 Sep 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 600,000
Exercise price: $0.3760
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares underlying the stock option vest on September 27, 2024, with the remaining shares vesting on a monthly basis on the 27th day of each month thereafter, in each case, subject to continuous service to the issuer, such that the option shall be fully vested on September 27, 2027.

SEC remarks

Chairman, President, and Chief Executive Officer.